JP Morgan Maintains Overweight on Guardant Health, Lowers Price Target to $85
JP Morgan analyst Julia Qin maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $100 to $85.
Stephens & Co. Maintains Overweight on Guardant Health, Lowers Price Target to $90
Stephens & Co. analyst Mason Carrico maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $99 to $90.
Credit Suisse Maintains Outperform on Guardant Health, Lowers Price Target to $70
Credit Suisse analyst Dan Leonard maintains Guardant Health (NASDAQ:GH) with a Outperform and lowers the price target from $80 to $70.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Stephens & Co. Initiates Coverage On Guardant Health with Overweight Rating, Announces Price Target of $99
Stephens & Co. analyst Mason Carrico initiates coverage on Guardant Health (NASDAQ:GH) with a Overweight rating and announces Price Target of $99.
Netflix, Biogen And Other Big Gainers From Wednesday
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
As part of President Joe Biden’s executive order to beef up U.S. biomanufacturing, the U.S. Department of Health and Human…
Biden Administration Pushes ‘Cancer Moonshot’ Initiative: Report
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it."
The President underscored his goal to cut the cancer death rate in the U.S. by at least 50% over the next 25 years.